| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.
|
J Clin Invest
|
2002
|
2.15
|
|
2
|
Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
|
Cancer Res
|
2002
|
2.05
|
|
3
|
Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression.
|
J Biol Chem
|
2005
|
1.64
|
|
4
|
Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase.
|
Hepatology
|
2009
|
1.54
|
|
5
|
Regulation of Rac1 activation by the low density lipoprotein receptor-related protein.
|
J Cell Biol
|
2002
|
1.35
|
|
6
|
Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.
|
J Clin Invest
|
2007
|
1.33
|
|
7
|
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly.
|
Hepatology
|
2008
|
1.31
|
|
8
|
Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases.
|
PLoS One
|
2010
|
1.10
|
|
9
|
Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis.
|
Hepatology
|
2007
|
1.10
|
|
10
|
Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
|
Hepatology
|
2010
|
1.04
|
|
11
|
tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.
|
J Am Soc Nephrol
|
2008
|
1.04
|
|
12
|
Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.
|
Exp Neurol
|
2009
|
1.01
|
|
13
|
The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock.
|
Hepatology
|
2005
|
1.01
|
|
14
|
Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.
|
Am J Pathol
|
2009
|
0.97
|
|
15
|
tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling.
|
Am J Pathol
|
2010
|
0.93
|
|
16
|
Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice.
|
Hepatology
|
2011
|
0.91
|
|
17
|
tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.
|
Am J Pathol
|
2010
|
0.91
|
|
18
|
Novel actions of tissue-type plasminogen activator in chronic kidney disease.
|
Front Biosci
|
2008
|
0.90
|
|
19
|
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene.
|
Hepatology
|
2011
|
0.87
|
|
20
|
Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis.
|
PLoS One
|
2013
|
0.86
|
|
21
|
Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
|
J Biol Chem
|
2002
|
0.85
|
|
22
|
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
|
Mod Pathol
|
2003
|
0.81
|
|
23
|
Protection against Fas-induced fulminant hepatic failure in liver specific integrin linked kinase knockout mice.
|
Comp Hepatol
|
2011
|
0.80
|
|
24
|
Fibrinolytic factors in liver fibrosis.
|
Curr Pharm Biotechnol
|
2011
|
0.79
|